Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,619 across all filing types
Latest filing 2020-02-21 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
关于召开2020年第一次临时股东大会通知的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2020 first extraordinary general meeting of shareholders for Shenzhen Haier Bioengineering Co., Ltd. It includes information about the meeting date, voting procedures (including online voting), agenda items for shareholder approval, registration details, and proxy authorization forms. The content focuses on notifying shareholders about the meeting and how to participate and vote on various proposals, including capital increases, bond issuance, guarantees, and related party transactions. There are no financial statements, management discussion, or detailed financial results presented. The document is not a report itself but a formal notice and instructions for a shareholder meeting. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-02-21 Chinese
关于关联方向公司提供借款暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a related party transaction where the company's controlling shareholders and related parties provide loans to the company. It includes information about the parties involved, the terms of the loans, the approval process by the board, independent directors' opinions, and the need for shareholder approval. The document is titled as an announcement and contains no financial statements or comprehensive financial data. It is not a full financial report but a regulatory announcement about a financing-related related party transaction. Given the content focuses on financing updates and related party loan transactions, the most appropriate classification is Capital/Financing Update (CAP). The document length is 4422 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is CAP with high confidence.
2020-02-21 Chinese
关于拟非公开发行短期公司债券（疫情防控债）预案的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a proposed non-public issuance of short-term corporate bonds by the company. It details the bond issuance plan, approval procedures, bond terms, intended use of proceeds, and requests authorization from the shareholders' meeting. There are no financial statements or detailed financial performance data included. The document is primarily an update on capital raising activities and the company's financing plans. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 2491 characters, which is consistent with an announcement rather than a full report.
2020-02-21 Chinese
独立董事关于第八届董事局第六次会议相关事项事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding a related-party loan transaction and its approval process. It references governance and regulatory guidelines but does not contain financial statements or detailed financial data. The document is short (489 characters) and serves as a governance or board-related announcement rather than a full report. It does not fit into financial reports like Annual Report or Interim Report, nor is it a certification or voting result. The content aligns best with Board/Management Information (MANG) as it concerns board-level approval and related-party transactions.
2020-02-21 Chinese
独立董事关于第八届董事局第六次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on specific board meeting matters, including guarantees and related party loans. It references compliance with stock exchange rules and company articles but does not contain financial statements or detailed financial results. It is a governance-related opinion on board decisions rather than a full management report or audit. The document length is short (898 characters), and it is not an announcement of a report but an opinion statement. This fits best under Board/Management Information (MANG), which covers announcements of board or senior management matters.
2020-02-21 Chinese
关于为控股子公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding guarantees provided for loans and supplier payments by its controlling subsidiaries. It includes extensive financial data and business descriptions of the subsidiaries involved. The content focuses on the company's provision of guarantees to support subsidiary financing, including specific guarantee amounts, conditions, and financial metrics of the subsidiaries. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. It is not a call transcript, nor a management or governance report. The document is a formal announcement about capital-related activities (providing guarantees for financing), which fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed financial data relevant to the guarantee decisions, supporting the classification as CAP rather than a brief announcement or regulatory filing.
2020-02-21 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.